Home › Companies › Biotechnology, Health Care, Oncology, Pharmaceutical, Therapeutics › Pinpoint Therapeutics
Pinpoint Therapeutics
Pinpoint Therapeutics is a preclinical stage company developing novel cancer treatment options aimed to specifically inhibit autophagy.
Pinpoint Therapeutics operates in biotechnology, health care, oncology, pharmaceutical, therapeutics based in Greater Philadelphia Area, Great Lakes, Northeastern US, founded in 2018.
The company sits in the biotechnology, health care, oncology, pharmaceutical, therapeutics segment, where it competes on its core product or service.
Its base of operations is Greater Philadelphia Area, Great Lakes, Northeastern US.
It is recorded at the Debt_Financing stage.
Recorded headcount: c_00051_00100 employees.
Public records show total funding of about $1M.
| Sector | Biotechnology, Health Care, Oncology, Pharmaceutical, Therapeutics |
|---|---|
| Headquarters | Greater Philadelphia Area, Great Lakes, Northeastern US |
| Founded | 2018 |
| Employees | c_00051_00100 |
| Stage | debt_financing |
| Total funding | $1,000,000 |
Website: www.pinpointtherapeutics.com
Browse related
Contact details and direct channels are available to signed-in members.
Create a free account
Create a free account